Clinical Trial Update: MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial called TREATMORE evaluating MethoTRExATE in myeloproliferative neoplasms is currently recruiting for polycythemia vera, essential throm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Polycythemia Vera (PV), Essential Thrombocythemia (ET) | Phase 2 | Status: RECRUITING